Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1777
Full metadata record
DC FieldValueLanguage
dc.contributor.authorREG NO: BG0121013-
dc.date.accessioned2025-04-26T09:35:26Z-
dc.date.available2025-04-26T09:35:26Z-
dc.date.issued2024-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/1777-
dc.description.abstractABSTRACT INTRODUCTION Lipoprotein (a) was identified as a variant of low-density lipoprotein (LDL) 40 years ago. Lipoprotein (a) consists of one LDL particle containing apoB-100 and one molecule of a large, highly polymorphic glycoprotein known as apo (a). The study aimed to evaluate and correlate the clinical significance of lipoprotein (a) as a risk factor for atherosclerotic vascular events in the elderly populationen_US
dc.language.isoen_USen_US
dc.publisherKLE Academy of Higher Education and Research, Belagavien_US
dc.titleEstimation and correlation of clinical Significance of lipoprotein (a) as a risk factor Of atherosclerotic vascular events in Elderly: a one year cross-sectional study in Kle’s dr prabhakar kore hospital and medical Research centre, belagavien_US
dc.typeDissertationsen_US
Appears in Collections:General Medicine MD

Files in This Item:
File Description SizeFormat 
BG0121013.pdf22.36 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.